Propagermanium, a CCR2 inhibitor, attenuates cerebral ischemia/reperfusion injury through inhibiting inflammatory response induced by microglia

Authors:
Publisher website
Google Scholar
Abstract
No abstract available
Funding Information
  • National Natural Science Foundation of China, China (81673442)
  • National Major Scientific and Technological Special Project for “Significant New Drugs Development” during the Thirteenth Five-year Plan Period, China (2016ZX09101031)
  • Qing Lan Project, China (2016)

This publication has 51 references indexed in Scilit: